Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-050863
Filing Date
2013-06-21
Accepted
2013-06-21 20:33:41
Documents
1
Period of Report
2013-06-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4965
  Complete submission text file 0001104659-13-050863.txt   6429
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 210 MAIN STREET WEST C/O BIOSANTE PHARMACEUTICALS, INC. BAUDETTE MN 56623
Business Address
Arnold Charlotte C. (Reporting) CIK: 0001579581 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 13928318